Cargando…
External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours
BACKGROUND: The Obermair nomogram was recently developed to predict the risk of relapse in patients with borderline ovarian tumours (BOTs) based on five readily available clinical, biological, and pathological characteristics. We set out to externally validate and assess its robustness using a multi...
Autores principales: | Bendifallah, S, Uzan, C, Fauvet, R, Morice, P, Darai, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844921/ https://www.ncbi.nlm.nih.gov/pubmed/24169360 http://dx.doi.org/10.1038/bjc.2013.678 |
Ejemplares similares
-
Response to ‘Comment on external multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'
por: Bendifallah, S, et al.
Publicado: (2014) -
Comment on ‘External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'
por: Obermair, A
Publicado: (2014) -
An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?
por: Bendifallah, S, et al.
Publicado: (2013) -
Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group
por: Ouldamer, Lobna, et al.
Publicado: (2016) -
Clinical outcome and risk factors for recurrence in borderline ovarian tumours
por: Yokoyama, Y, et al.
Publicado: (2006)